Already used off-label for psoriasis - and approved for rheumatoid arthritis and psoriatic arthritis - Amgen Inc.'s Enbrel (etanercept) won FDA approval for treating those with moderate to severe forms of the skin condition who are candidates for systemic therapy or phototherapy. (BioWorld Today) Read More